Related Experiment Video

Updated: Dec 28, 2025

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
08:21

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Published on: October 26, 2020

5.4K

[Treatment of coronary artery disease in renal insufficiency]

K Lopau1, C Wanner2

  • 1Medizinische Klinik und Poliklinik 1, Schwerpunkt Nephrologie, Universitätsklinikum Würzburg, Oberdürrbacher Str. 6, 97080, Würzburg, Deutschland.

Der Internist
|February 13, 2020
PubMed

Insights

Treatment for stable coronary artery disease varies by chronic kidney disease (CKD) stage. Guidelines address standard care and revascularization, but acute event management requires further study.

Area of Science:

  • Nephrology
  • Cardiology
  • Internal Medicine

Background:

  • Coronary artery disease (CAD) management in chronic kidney disease (CKD) patients requires tailored approaches based on CKD stage.
  • German national guidelines and Kidney Disease - Improving Global Outcomes (KDIGO) recommendations guide treatment for varying kidney function levels.

Purpose of the Study:

  • To outline current treatment strategies for stable coronary artery disease in patients with different stages of chronic kidney disease.
  • To highlight the need for evidence-based approaches in managing acute cardiovascular events in CKD patients.

Main Methods:

  • Review of existing national guidelines and KDIGO recommendations for CAD management in CKD.
  • Analysis of treatment strategies including standard medical therapy and revascularization based on patient demographics and CKD severity.

Main Results:

  • Standard care for cardiovascular disease in CKD involves aspirin, statins, beta-blockers, RAS inhibitors, and SGLT2 inhibitors.
  • Revascularization strategies are pragmatic for older, comorbid patients; younger patients may benefit from surgery.
  • Acute event management is currently independent of kidney function, lacking a consensus strategy.

Conclusions:

  • Treatment for stable CAD must be individualized according to CKD stage.
  • Further controlled studies are essential to establish optimal management strategies, particularly for acute cardiovascular events in CKD patients.

Keywords:
Acetylsalicylic acidAdrenergic beta-antagonistsAngiotensin receptor antagonistsHydroxymethylglutaryl-CoA reductase inhibitorsPercutaneous coronary intervention

More Related Videos

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

3.9K
Use of a Hanging-weight System for Isolated Renal Artery Occlusion07:54

Use of a Hanging-weight System for Isolated Renal Artery Occlusion

Published on: July 19, 2011

16.4K

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
186
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
832
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
281
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
364
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
161
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
228